Dr. Sunil Kumar

Curriculum Vitae 

Name:                  SUNIL KUMAR 

Designation:       ADDITIONAL PROFESSOR, SURGICAL ONCOLOGY  

Other Affiliations / Honorary positions: Managing Trustee, Chandrakanti Devi Cancer Foundation (A Non-Governmental Organization) www.cancerhelpnet.in

 

Educational Qualifications &Fellowships:        MS, FACS, FICS, FAIS 

 

Areas of Clinical Interest:                         Thoracic cancers, Hepato-biliary tumors, Vascular reconstructive surgery for arcomas

 

Awards/Honors :          V. Ramalingaswami Medal for the Best Intern at AIIMS, New Delhi  

Memberships:    1. International Association for the Study of Lung Cancer

                             2. European Society of Surgical Oncology

                             3. Association of Surgeons of India

                             4. International College of Surgeons

                             5. American College of Surgeons

 

Research:  

Total number of Research Projects involved

As PI -                  5

As Co-PI -             12

 

Title and list of Funded research Projects (As PI)

1. Comparision of pulmonary metastasis detected with PET-CT vs NCCT chest with surgical pathology
2. Clinical significance of cell-free DNA in intraoperative pleural lavage fluid and plasma in patients undergoing pulmonary metastasectomy: A pilot study
3. Patterns of Care and Survival Studies on Gall Bladder Cancer under ICMR- National Cancer Registry Programme (NCRP)
4. Predicting the response to neo-adjuvant chemotherapy by analysis of  exome and transcriptome in squamous cell carcinoma of esophagus

 

Publications:  

Total Number of publications:       51

 

Chapters in Books:       5

 

Editor of Books

 

Ten best Publications:

 

 

1. Neoadjuvant chemotherapy followed by surgery in lung cancer: Indian scenario

Sunil Kumar, Jyoutishman Saikia, Vinay kumar JR, Prabhat S. Malik, Karan Madan, Deepali Jain, Sachidanand Bharati

Current Problems in Cancer 2020, https://doi.org/10.1016/j.currproblcancer.2020.100563

1. Neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of esophagus: Clinical profile and outcomes from tertiary care cancer centre

N Kumar, S Deo, N Shukla, S Bhoriwal, A Sharma, R Pramanik, R Sahoo, S Kumar

Annals of Oncology Vol 29 (2018) https://doi.org/10.1093/annonc/mdy151.047

1. Limb preservation using vascular reconstruction in patients with large extremity soft tissue sarcomas: results of multi-modality therapy

Sunil Kumar, N. M. L. Manjunath, S. Manoj Gowda, Naveen Kumar, Sachidanand Bharati, S. V. S. Deo

Indian Journal of Surgery 2020, https://doi.org/10.1007/s12262-020-02161-7

1. Multimodality management of incidentally detected gall bladder cancer: long term results from a tertiary care cancer centre

Sunil Kumar, SandeepBhoriwal, DillipMuduly, MadhabanandaKar, Atul Sharma, SushmitaPathy, Nootan Kumar Shukla, SV SuryanarayanaDeo

J GastrointestOncol 2018  doi: 10.21037/jgo.2018.09.10

1. Fatigue and functional ability in patients undergoing upfront surgical treatment for solid malignancies

Parveen, Naveen Kumar, Aditi Prashant Sinha, Rakesh Garg, S. V. S. Deo, Sunil Kumar

Indian Journal of Surgical Oncologydoi.org/10.1007/s13193-019-00918-5

1. Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial

Atul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, V. Sreenivas, Ranjit Kumar Sahoo, Nootan Kumar Shukla, Sanjay Thulkar, Sujoy Pal, Surya V. Deo, Sushmita Pathy, Nihar Ranjan Dash, Sunil Kumar, Sushma Bhatnagar, Rakesh Kumar, Seema Mishra, Peush Sahni, Venkateswaran K. Iyer, Vinod Raina

European Journal of Cancer 123 (2019) 162-170

1. Displaced Cartilage Within Lymph Node Parenchymais a Novel Biopsy Site Change in Resected MediastinalLymph Nodes Following EBUS-TBNA

Erika E. Doxtader, MD, Lara Pijuan, MD, PhD,Marcos Lepe, MD,Deepu Alex, MD, PhD,MarianaCanepa, MD,Amy H. Deeken, MD, Jean-Baptiste Gibier, MD, Deepali Jain, MD,NafisehJanaki, MD,Alexis Jelinek, MD, Sunil Kumar, MD,Tania Labiano, MD,VincenzoL’Imperio, MD,Claire Michael, MD,Fabio Pagni, MD,AngelPanizo, MD, PhD, Liza M. Quintana, MD, Sinchita Roy-Chowdhuri, MD, PhD,Albert Sanchez-Font, MD, PhD, Daniel C. Skipper, DO,Laura S. Spruill, MD, PhD,VandaTorous, MD, Roseann I. Wu, MD, MPH,Jennifer L. Sauter, MD,and Sanjay Mukhopadhyay, MD

Am J Surg Pathol 2018 doi: 10.1097/PAS.0000000000001197

1. Clinicopathologic correlation of programmed death ligand-1 expression in non-small cell lung carcinomas: A report from India

Archana George Vallonthaiel, Prabhat Singh Malik, Varsha Singh, Vinay Kumar, Sunil Kumar, Mehar Chand Sharma, SandeepMathur, SudheerArava, RandeepGuleria,Deepali Jain

Annals of Diagnostic Pathology 31 (2017) 56–61

1. PD-L1 immuno-expression assay in thymomas: Study of 84 cases and review of literature

Prerna Guleria, Nuzhat Husain, Saumya Shukla, Sunil Kumar, RajinderParshad, Deepali Jain

Annals of Diagnostic Pathology 34 (2018) 135–141

1. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward

Abhishek Shankar, Deepak Saini, Anusha Dubey, Shubham Roy, SachidanandJee Bharati, Navneet Singh…Sunil Kumar, et al

Translational Lung Cancer Researchdoi: 10.21037/tlcr.2019.03.03

10. Primary ectopic mediastinal goiter in a patient with Crohn’s disease presenting as myasthenia gravis.

Sunil Kumar, Mahesh Sultania, Shivam Vatsal, MC Sharma                              Ann Thorac Surg 2015;100:2333–6